China Inonzwisisika mutengo Mini-Clia - 2019-nCOV IgGIgM Rapid Test Device(single service) Vagadziri uye vatengesi -

Mutengo unonzwisisika Mini- Clia - 2019 - nCOV IgGIgM Rapid Test Device (kamwe kushumira) - Realy

Reasonable price Mini-Clia – 2019-nCOV IgGIgM Rapid Test Device(single serving) – Realy

Tsanangudzo Pfupi:

Tumira email kwatiri Dhaunirodha sePDF

Product Detail

FAQ

Pfupiso Yekuchengetedza uye Kuita

Product Tags

Kuwana kugutsikana kwevatengi ndicho chinangwa chefemu yedu kune zvakanaka. Tichaita nhamburiko dzinoshamisa kugadzira zvinhu zvitsva uye zvemhando yepamusoro - zvemhando yepamusoro, kusangana nezvakakosha zvaunoda uye kukupa pre-sale, pa-kutengesa uye shure-kutengesa zvigadzirwa nemasevhisiRopa Kuedzwa KwePneumonia,Novel Coronavirus Test,Antibody Rapid Test, Kuvavarira nesimba kuti uwane budiriro inoenderera yakavakirwa pamhando, kuvimbika, kuvimbika, uye kunzwisisa kwakazara kwekuchinja kwemusika.

Mutengo unonzwisisika Mini- Clia - 2019-nCOV IgGIgM Rapid Test Device(kamwe kushumira) - RealyDetail:

Sensitivity and Specificity

Yekuongorora IgG:

Nzira		RT-PCR		Total Results
2019 - nCOV IgG/IgM Rapid Test Device	Results	Positive	Negative	Total Results
	Positive	233	2	235
	Negative	35	287	322
Total Results		268	289	557

Relative Sensitivity:233/268=86.94%(95%CI*:82.35%-90.49%)

Zvine hukama:287/289=99.31% (95%CI*:97.52%-99.92%)

Kururama:520/557=93.36% (95%CI*: 90.96%-95.16%)

*Chivimbo Interval

Yekuongorora IgM

Nzira		RT-PCR		Total Results
2019 - nCOV IgG/IgM Rapid Test Device	Results	Positive	Negative	Total Results
	Positive	223	7	230
	Negative	45	282	327
Total Results		268	289	557

Relative Sensitivity:223/268=83.21% (95%CI*:78.19%-87.48%)

Zvinoenderana nehunhu:282/289=97.58% (95%CI*: 95.07%-99.02%)

Kururama: 505/557=90.66% (95%CI*: 87.94%-92.95%)

*Chivimbo Interval

Iyo 2019-nCOV/COVID-19 IgG/IgM Rapid Test Device inokurumidza chromatographic immunoassay yekuonekwa kwemhando yeIgG&IgM antibody yeCoronavirus Chirwere 2019 muropa revanhu rese, serum, kana plasma serubatsiro mukuongororwa kweCOVID-19 hutachiona.

KUSHANDISWA KWAKAVANGWA: Iyo 2019 - nCOV/COVID - 19 IgG/IgM Rapid Test Device inokurumidza chromatographic immunoassay yekuonekwa kwemhando yeIgG&IgM antibody yeCoronavirus Chirwere 2019 muropa revanhu rose, serum, kana plasma serubatsiro mukuongororwa kweCOVID19.

SUMMARY: COVID-19 chirwere chekufema chinotapukira. Vanhu vanowanzo batwa nedambudziko iri. Parizvino, varwere vakatapukirwa neinoveli coronavirus ndiyo honzeri yehutachiona; asymptomatic vanhu vane hutachiona vanogona zvakare kuve nehutachiona sosi. Zvichienderana neazvino epidemiological kuferefeta, iyo incubation nguva ndeye 1 kusvika 14 mazuva, kazhinji 3 kusvika 7 mazuva. Zviratidzo zvikuru zvinosanganisira fivha, kuneta uye chikosoro chakaoma. Nasal congestion, runny mhino, kurwadziwa kwehuro, myalgia uye manyoka zvinowanikwa mune zvishoma.

NZIRA YEKUSHANDISA: Bvumira mudziyo wekuyedza, saizi, buffer, uye/kana zvidhiraivho kuti zvisvike tembiricha yemumba (15-30°C) isati yaedzwa. 1. Hunza homwe yacho kune tembiricha yemumba usati wavhura. Bvisa mudziyo wekuyedza kubva muhomwe yakavharwa woishandisa nekukasika. 2. Isa mudziyo wekuedza panzvimbo yakachena uye yakaenzana. ? YeSerum kana Plasma Zvimiro: Uchishandisa iyo yakapihwa 10μL inoraswa pipette, dhirowa mufananidzo kumusoro weKuzadza Line, uye endesa 10μL serum/plasma kune yemuenzaniso tsime rebvunzo mudziyo, wobva wawedzera madonhwe maviri ebhafa uye tanga iyo timer. ? YeRopa Rakazara (Venipuncture/Fingerstick) Sayenzi: Uchishandisa yakapihwa 10μL pipette inoraswa, uye kuendesa donhwe rimwe reropa rose (ringaita 20μL) kumuenzaniso wetsime rebvunzo mudziyo, wobva wawedzera madonhwe maviri ebhafa uye wotanga timer. Ongorora: Zvimiro zvinogona zvakare kuiswa uchishandisa micropipette. 3. Mirira kuti mitsetse ine mavara ionekwe. Verenga zvabuda pamaminetsi gumi. Usadudzire zvawanikwa mushure memaminitsi gumi nemashanu.

sdv

ZVINOTAURWA: Kiti iyi inoshandisa immunochromatography.Kadhi rebvunzo rine:1) colloidal gold-yakanyorwa recombinant novel coronavirus antigen uye quality control antibody goridhe markers;2) mitsara miviri yekuona (IgG neIgM mitsara) uye imwe yemhando Kudzora mutsara (C mutsara) yenitrocellulose membrane. Mutsara weM haufambiswe ne monoclonal anti-yemunhu IgM antibody yekuona novel coronavirus IgM antibody; iyo IgG mutsara inovharwa neiyo reagent yekuona riini coronavirus IgG antibody; uye C mutsara haifambiswi nemhando yekudzivirira antibody. Kana huwandu hwakakodzera hwesample yebvunzo yawedzerwa pagomba remuenzaniso wekadhi rebvunzo, sample inoenda kumberi nekadhi rebvunzo pasi pekuita kwecapillary. Iyo immune complex inobatwa neiyo anti - yemunhu IgM antibody isingafambiswe pa membrane kugadzira yepepuru - tsvuku M mutsara, zvichiratidza kuti novel coronavirus IgM antibody yakanaka. Kana sampuro iine IgG antibody, antibody inosungirira kune colloidal goridhe - yakanyorwa novel coronavirus antigen, uye iyo immune complex inobatwa neiyo reagent isina kufambisa pa membrane kugadzira yepepuru - tsvuku IgG mutsara, zvichiratidza kuti novel coronavirus IgG antibody yakanaka. Kana mitsara yeIgG neIgM isina mavara, chigumisiro chisina kunaka chinoratidzwa.Kadhi yekuongorora inewo mutsara wehutano hwehutano C. Fuchsia quality control line C inofanira kuonekwa pasinei nokuti mutsara wekuedza unowanikwa.Mutambo wehutano wehutano ibhande remavara ehutano hwekudzivirira antibody immune complex. Kana iyo yemhando yekudzora mutsara C ikasaoneka, mhedzisiro yebvunzo haina kunaka, uye sampuro inoda kuongororwa zvakare neimwe kadhi rekuyedza.